|
The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: ---------- Renalytix PLC - London-based diagnostics company - Clarifies that the forward revenue guidance provided on Tuesday does not include full consideration of the implications of its recently announced collaboration with Tempus AI Inc. Renalytix says it is too early to predict revenue contributions from the new relationship. On Tuesday, the firm said it expects to report $8.4 million in revenue in financial 2026, down from previous guidance for revenue of $8.5 million in its March half year report. It expects revenue of $19.0 million in financial 2027, up from the previous outlook of $17.5 million. Renalytix set expectations for revenue of $42.0 million in financial 2028. In addition, raises just over £1.0 million via subscription by ABRDN World Healthcare Fund for 11 million shares at 9.5 pence each. This is further to the recently announced placing and subscription. Funds raised will further support the commercial distribution efforts, which includes the recently announced collaboration with Tempus. Chief Executive James McCullough says: ‘We are particularly pleased with the strong institutional support we have received at this critical time for accelerating growth with our US kidneyintelX.dkd prognostic testing and unique data accumulation program in diabetes and kidney disease.’ ---------- Alien Metals Ltd - Australia-focused minerals explorer and developer - Reports that its joint venture partner, West Coast Silver Ltd, has awarded the phase 2 drill contract at the Elizabeth Hill Silver Project to Wallis Drilling Pty Ltd and reported further high-grade silver intercepts from its inaugural diamond programme at Elizabeth Hill in the Pilbara region of Western Australia. The project, in which Alien retains a 30% free-carried interest through to a decision to mine, is operated by WCE. Drilling will consist of a combination of diamond and air core drilling, with multiple objectives targeted, and will start in 4 to 6 weeks. ‘We are very encouraged by these latest high grade silver intercepts from Elizabeth Hill which supports the potential to grow the mineralised footprint around the historical mine. The decision to award the phase 2 drill programme is welcome as it will focus on additional near-surface targets and step-outs, alongside the existing high grade silver intercepts,’ company says. ---------- Genedrive PLC - Manchester-based point-of-care pharmacogenetic testing company - Completes its placing of 1.60 billion shares at 0.20 pence, raising around £3.2 million in total. Proceeds will be used to support the group’s near-term commercialisation and market expansion activities throughout the UK, Europe and the Middle East. In addition, says has received an additional indication of interest from a prospective investor to invest around £100,000 on the same terms as the placing. Discussions remain ongoing. ---------- Canal+ SA - Paris-based media and telecommunications conglomerate - Starts a new share buyback programme for up to £31 million to meet share awards to employees and corporate officers made under its share-based incentive plans. The buyback will start on Thursday and run until December 19. ---------- Yellow Cake PLC - Jersey-based investment company which offers exposure to the uranium spot price - Raises $175 million from upsized placing at 564 pence per share, due to ‘strong investor demand’. The firm had looked to raise $125 million. Additional proceeds will fund ‘opportunistic and strategic purchases’ of further uranium. ‘We are delighted with the strong support from both existing and new institutional investors in this significantly upsized placing,’ company says. ---------- Jade Road Investments Ltd - Hong Kong-based investment company - Pretax loss widens to $438,000 in the six months to June 30 from $401,000 the year prior. Basic and diluted loss per share is 1.15 US cents compared to 1.10c. Says accounts for the 2024 financial year and the first half of 2025 reflect limited activity, comprising only essential operating expenses alongside non-cash interest and fair value charges recognised through profit or loss on certain financial instruments. ---------- WAG Payment Solutions PLC - London-based firm known as Eurowag is a payments and mobility platform servicing the European commercial road transport industry - Bock Capital EU Luxembourg WAG Sarl, an affiliate of TA Associates Management LP plans to sell £50 million worth shares of its current 25.9% stake. The sale and the price per share will be determined by way of an accelerated bookbuild to institutional investors. Peel Hunt LLP is appointed as sole bookrunner in respect of the placing. ---------- Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
